Prevention of invasive meningococcal infection;Prävention von invasen meningokokkeninfektionen

Monatsschrift fur Kinderheilkunde

Volumn 150, Issue 8, 2002, Pages 1005-1015

  Heininger, U ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIBODY CONJUGATE; BACTERIAL POLYSACCHARIDE; CEFTRIAXONE; CIPROFLOXACIN; MENINGOCOCCUS VACCINE; NEISVAC; PENICILLIN G; POLYSACCHARIDE VACCINE; RIFAMPICIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BACTEREMIA; BACTERIAL MEMBRANE; BLOOD GROUP TYPING; DISEASE TRANSMISSION; EPIDEMIC MENINGITIS; EUROPE; FEVER; GERMANY; HUMAN; INCIDENCE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENESIS; PATIENT COMPLIANCE; REVIEW; RISK FACTOR; SEASONAL VARIATION; SEROTYPING; SIDE EFFECT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 0036956311     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-002-0519-7     Document Type: Review

References (8)

1. Borrow R, Goldblatt D, Andrews N, Richmond P, Southern J, Miller E (2001) Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children. J Infect Dis 184: 377-380
2. Connolly M, Noah N (1999) Is group C meningococcal disease increasing in Europe? A report of surveillance of meningococcal infection in Europe 1993-6. Epidemiol Infect 122: 41-44
3. De Wals P, De Serres G, Niyonsenga T (2001) Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec. JAMA 285: 177-181
4. Heininger U (2001) Impfratgeber. UNI-MED Verlag, Bremen
5. Lieberman JM, Chiu SS, Wong VK, Partidge S, Chang SJ, Chiu CY, Gheesling LL, Carlone GM, Ward JI (1996) Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial. JAMA 275: 1499-1503
6. Peltola H, Makela H, Kayhty H, Jousimies H, Herva E, Hallstrom K, Sivonen A, Renkonen OV, Pettay O, Karanko V, Ahvonen P, Sarna S (1977) Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 297: 686-691
7. Ramsay ME, Andrews N, Kaczmarski EB, Miller E (2001) Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357:195-196
8. Robert Koch-Institut (1999) Ratgeber Infektionskrankheiten. 2. Folge: Meningokokken-Erkrankungen. Epidemiol Bull 11